Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.9
-18.91%
40%
โ
-98.91%
20%
โ
5 Years
Score2.9
Net Growth-18.91%
Net Trend40%
Net Income Consistencyโ
Rev Growth-98.91%
Rev Trend20%
Revenue Consistencyโ
See the full market ranking โ
Avalo Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 6M to $ 59K and net income went from -$ 63M to -$ 78M. Revenue increased in 1 of those 5 years; net income in 2.
Between 2015 and 2025, net income went from -$ 10M to -$ 78M. Revenue increased in 2 of those 10 years; net income in 4.
Avalo Therapeutics Inc currently holds a 5-year HDB Score of 2.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 19.55 | โ |
1 Year2025-08-12 | $ 9.36 | 108.87% |
5 Years2021-08-12 | $ 8.44K | -99.77% |
10 Years2016-08-12 | $ 11.58K | -99.83% |
All Time2015-11-13 | $ 11.52K | -99.83% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-11-13 |
|---|---|---|---|---|---|
| Price | $ 19.55 | $ 9.36 | $ 8.44K | $ 11.58K | $ 11.52K |
| Return | โ | 108.87% | -99.77% | -99.83% | -99.83% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 59K | -$ 100M | $ 400M |
| 2025 | $ 59K | -$ 78M | $ 98M |
| 2024 | $ 441K | -$ 35M | $ 134M |
| 2023 | $ 1M | -$ 31M | $ 7M |
| 2022 | $ 18M | -$ 41M | $ 13M |
| 2021 | $ 5M | -$ 84M | $ 54M |
| 2020 | $ 6M | -$ 63M | $ 18M |
| 2019 | $ 6M | -$ 16M | $ 11M |
| 2018 | $ 18M | -$ 40M | $ 10M |
| 2017 | $ 27M | $ 11M | $ 2M |
| 2016 | $ 1M | -$ 16M | $ 5M |
| IPO2015 | -$ 10M | $ 21M |
Explore beyond AVTX
You're looking at Avalo Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
